Insight Molecular Diagnostics (IMDX) Capital Expenditures Growth (5y) (2020 - 2026)
Insight Molecular Diagnostics (IMDX) Capital Expenditures Growth (5y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn |
| 10 | Insight Molecular Diagnostics | 4.52 Mn | -24.41 Mn | 15,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.15% |
| Dec 31, 2025 | 54.87% |
| Sep 30, 2025 | 14.83% |
| Jun 30, 2025 | -6.60% |
| Mar 31, 2025 | 47.48% |
| Dec 31, 2024 | -24.97% |
| Jun 30, 2024 | 76.98% |
| Mar 31, 2024 | 27.94% |
| Sep 30, 2023 | -130.22% |
| Dec 31, 2022 | 166.20% |
| Sep 30, 2022 | 95.60% |
| Jun 30, 2022 | 95.65% |
| Mar 31, 2022 | 149.95% |
| Dec 31, 2021 | 35.75% |
| Sep 30, 2021 | 112.94% |
| Jun 30, 2021 | 162.23% |
| Mar 31, 2021 | 123.79% |
| Dec 31, 2020 | -19.43% |
| Mar 31, 2020 | 31.95% |